EQS-News: ENCAVIS AG / Key word: 9 Month figures/Quarterly / Interim Statement
ENCAVIS AG grows in turbulent times and increases operating earnings per share by around 4%.
EQS-News: ENCAVIS AG grows in turbulent times and increases operating earnings per share by around 4% finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Basilea Pharmaceutica AG: Basilea announces exclusive license and option agreement for potential first-in-class clinical-stage antibacterial agent finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.